140 (PB-140) Poster - Real-World Comparison of Overall Survival in Female Patients with HR+/HER2- Metastatic breast cancer receiving endocrine therapy, endocrine therapy plus palbociclib, or chemotherapy.

Authors :: Rizwan, U.
Hussain, R.
Kanagala, G.
Source :: European Journal of Cancer. Mar2024:Supplement 1, Vol. 200, pN.PAG-N.PAG. 1p.
Publication Year :: 2024

Subjects :: *THERAPEUTIC use of antineoplastic agents
*PROTEIN kinase inhibitors
*HORMONE receptor positive breast cancer
*CONFERENCES & conventions
*CANCER chemotherapy
*DRUG efficacy

Full Text Access

Tools